MVA-BN Yellow Fever Vaccine (Bavarian Nordic)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMVA-BN Yellow Fever Vaccine (Bavarian Nordic)
Drug Alias NameMVA-BN-YF
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsYellow Fever
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBavarian Nordic A/S
China Registration ClassN/A

Develop Information

Active CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)Bavarian Nordic A/S
Inactive CompaniesN/A
Active IndicationsYellow Fever
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A